News

The President-Elect of the AAPAL sat down with Psychiatric Times at the 2024 APA Annual Meeting to discuss building leaders.

This 2024 APA Annual Meeting poster investigated the relationship between antiobesity agents like semaglutide and depression.

Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.

Speakers at the APA Annual Meeting share insights regarding to disability, both in patients and in clinicians.

Are individuals with bipolar disorder more likely to die from unnatural causes than the general population?

What makes this treatment option unique?

What are the connections between cannabis use and the onset of psychotic disorders?

This 2024 APA Annual Meeting poster covered a literature review on the relationship between stimulant use and failure to thrive in pediatric patients with ADHD.

Use this protocol, presented at the 2024 APA Annual Meeting, in patients with cannabis use disorder to bolster likelihood of cannabis cessation or reduction in use.

This interactive installation begs the question, “What is the truth of life with schizophrenia?”

What is the potential impact of social media overuse and mental health crises in young patients?

A look at 3 different psychiatric perspectives for successfully diagnosing ADHD in previously undiagnosed adults.

Explore treatment resistance at the 2024 APA Annual Meeting!

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

An expert gives us a preview of the clinical pearls clinicians can expect from his presentations at this year’s APA Annual Meeting.

Which is the best recommendation for the treatment of alcohol use disorder?

What is new in research on major depressive disorder?

Don't miss these 2 APA Annual Meeting sessions on personality disorders!

We asked some of the presenters and attendees of the upcoming 2024 APA Annual Meeting what they were excited about. Here's what they said.

Frontal lobe syndrome can present with a range of behaviors that do not meet traditional dementia/neurocognitive disorder criteria.

The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.

How a radical proposal from California and 3 cases of anorexia nervosa from Colorado exemplify the "slippery slope" of physician-assisted suicide.

“The fundamental act of medical care is assumption of responsibility.”

Our Editorial Board members are delivering expert perspectives on a wide variety of psychiatric issues and disorders.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

What are the cultural psychiatry perspectives on personality disorders? Don't miss this APA session!

A late eulogy for George Tarjan, MD…

Wisdom, age, and the presidential election...

Challenging what is normal and the value of order.